Hitoshi Takizawa

Prof. Hitoshi Takizawa

International Research Center for Medical Sciences, Kumamoto University
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2012 in Blood
Verified
Journal Article
Closed access
PDF file
HTHitoshi Takizawa
Hitoshi Takizawa
SBSteffen Boettcher
Steffen Boettcher
MMMarkus G. Manz
Markus G. Manz
During systemic infection and inflammation, immune effector cells are in high demand and are rapidly consumed at sites of need. Although adaptive immune cells have high proliferative potential, innate immune cells are mostly postmitotic and need to be replenished from bone marrow (BM) hematopoietic stem and progenitor cells. We here review how early hematopoiesis has been shaped to deliver efficient responses to increased need. On the basis of most recent findings, we develop an integrated view of how cytokines, chemokines, as well as conserved pathogen structures, are sensed, leading to divisional activation, proliferation, differentiation, and migration of hematopoietic stem and progenitor cells, all aimed at efficient contribution to immune responses and rapid reestablishment of hematopoietic homeostasis. We also outline how chronic inflammatory processes might impinge on hematopoiesis, potentially fostering hematopoietic stem cell diseases, and, how clinical benefit is and could be achieved by learning from nature.

17 March 2014 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MBMarie-Luise Berres
Marie-Luise Berres
KLKaren Phaik Har Lim
Karen Phaik Har Lim
TPTricia Peters
Tricia Peters
JPJeremy Price
Jeremy Price
HTHitoshi Takizawa
Hitoshi Takizawa
CACarl E. Allen
Carl E. Allen
Langerhans cell histiocytosis (LCH) is a clonal disorder with elusive etiology, characterized by the accumulation of CD207+ dendritic cells (DCs) in inflammatory lesions. Recurrent BRAF-V600E mutations have been reported in LCH. In this study, lesions from 100 patients were genotyped, and 64% carried the BRAF-V600E mutation within infiltrating CD207+ DCs. BRAF-V600E expression in tissue DCs did not define specific clinical risk groups but was associated with increased risk of recurrence. Strikingly, we found that patients with active, high-risk LCH also carried BRAF-V600E in circulating CD11c+ and CD14+ fractions and in bone marrow (BM) CD34+ hematopoietic cell progenitors, whereas the mutation was restricted to lesional CD207+ DC in low-risk LCH patients. Importantly, BRAF-V600E expression in DCs was sufficient to drive LCH-like disease in mice. Consistent with our findings in humans, expression of BRAF-V600E in BM DC progenitors recapitulated many features of the human high-risk LCH, whereas BRAF-V600E expression in differentiated DCs more closely resembled low-risk LCH. We therefore propose classification of LCH as a myeloid neoplasia and hypothesize that high-risk LCH arises from somatic mutation of a hematopoietic progenitor, whereas low-risk disease arises from somatic mutation of tissue-restricted precursor DCs.

14 November 2016 in Frontiers in Immunology
Verified
Journal Article
Open access
LKLarisa V. Kovtonyuk
Larisa V. Kovtonyuk
KFKristin Fritsch
Kristin Fritsch
XFXiaomin Feng
Xiaomin Feng
MMMarkus G. Manz
Markus G. Manz
HTHitoshi Takizawa
Hitoshi Takizawa
All hematopoietic and immune cells are continuously generated by hematopoietic stem cells (HSCs) and progenitors (HPCs) through highly organized processes of stepwise lineage commitment. In the steady state, HSCs are mostly quiescent, while HPCs are actively proliferating and contributing to daily hematopoiesis. In response to hematopoietic challenges, e.g., life-threatening blood loss, infection, and inflammation, HSCs can be activated to proliferate and form blood components. The HSC activation induced by hematopoietic demand is mediated by direct or indirect sensing mechanisms involving pattern recognition receptors or cytokine/chemokine receptors. In contrast to hematopoietic challenges producing obvious clinical symptoms, how the aging process, which involves low-grade chronic inflammation, impacts hematopoiesis remains unknown. Herein, we summarize recent findings pertaining to functional alternations in hematopoiesis, HSCs and the bone marrow (BM) microenvironment during the processes of aging and inflammation. We highlight some common cellular and molecular changes during these processes that influence hematopoiesis and its cells of origin, HSCs and HPCs, as well as the BM microenvironment. We also discuss how age-dependent immune system alterations lead to subclinical inflammatory states and how inflammatory signaling might be involved in hematopoietic aging. Our aim is to present evidence supporting the concept of “Inflamm-Aging”, or inflammation-associated aging of hematopoiesis.

21 March 2013 in Annual Review of Immunology
Verified
Journal Article
Closed access
ARAnthony Rongvaux
Anthony Rongvaux
HTHitoshi Takizawa
Hitoshi Takizawa
TSTill Strowig
Till Strowig
Tim WillingerTim Willinger
Tim Willinger
EEElizabeth E. Eynon
Elizabeth E. Eynon
MMMarkus G. Manz
Markus G. Manz
To directly study complex human hemato-lymphoid system physiology and respective system-associated diseases in vivo, human-to-mouse xenotransplantation models for human blood and blood-forming cells and organs have been developed over the past three decades. We here review the fundamental requirements and the remarkable progress made over the past few years in improving these systems, the current major achievements reached by use of these models, and the future challenges to more closely model and study human health and disease and to achieve predictive preclinical testing of both prevention measures and potential new therapies.

7 February 2011 in Journal of Experimental Medicine
Verified
Journal Article
Open access
HTHitoshi Takizawa
Hitoshi Takizawa
RRRoland R. Regoes
Roland R. Regoes
CBChandra S. Boddupalli
Chandra S. Boddupalli
SBSebastian Bonhoeffer
Sebastian Bonhoeffer
MMMarkus G. Manz
Markus G. Manz
Hematopoietic stem cells (HSCs) maintain blood production. How often mouse HSCs divide and whether each HSC contributes simultaneously, sequentially, or repetitively to hematopoiesis remains to be determined. We track division of 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE)–labeled HSC in vivo. We found that, in steady-state mice, bone marrow cells capable of reconstituting lifelong hematopoiesis are found within both fast-cycling (undergoing five or more divisions in 7 wk) and quiescent (undergoing zero divisions in 12–14 wk) lineage marker–negative c-Kit+ Sca-1+ populations. The contribution of each population to hematopoiesis can fluctuate with time, and cells with extensive proliferative history are prone to return to quiescence. Furthermore, injection of the bacterial component lipopolysaccharide increased the proliferation and self-renewal capacity of HSCs. These findings suggest a model in which all HSCs undergo dynamic and demand-adapted entry into and exit out of the cell cycle over time. This may facilitate a similar degree of turnover of the entire HSC pool at the end of life.

11 February 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
CSCeleste Scotti
Celeste Scotti
EPElia Piccinini
Elia Piccinini
HTHitoshi Takizawa
Hitoshi Takizawa
ATAtanas Todorov
Atanas Todorov
PBPaul Bourgine
Paul Bourgine
IMIvan Martin
Ivan Martin
Embryonic development, lengthening, and repair of most bones proceed by endochondral ossification, namely through formation of a cartilage intermediate. It was previously demonstrated that adult human bone marrow-derived mesenchymal stem/stromal cells (hMSCs) can execute an endochondral program and ectopically generate mature bone. Here we hypothesized that hMSCs pushed through endochondral ossification can engineer a scaled-up ossicle with features of a “bone organ,” including physiologically remodeled bone, mature vasculature, and a fully functional hematopoietic compartment. Engineered hypertrophic cartilage required IL-1β to be efficiently remodeled into bone and bone marrow upon subcutaneous implantation. This model allowed distinguishing, by analogy with bone development and repair, an outer, cortical-like perichondral bone, generated mainly by host cells and laid over a premineralized area, and an inner, trabecular-like, endochondral bone, generated mainly by the human cells and formed over the cartilaginous template. Hypertrophic cartilage remodeling was paralleled by ingrowth of blood vessels, displaying sinusoid-like structures and stabilized by pericytic cells. Marrow cavities of the ossicles contained phenotypically defined hematopoietic stem cells and progenitor cells at similar frequencies as native bones, and marrow from ossicles reconstituted multilineage long-term hematopoiesis in lethally irradiated mice. This study, by invoking a “developmental engineering” paradigm, reports the generation by appropriately instructed hMSC of an ectopic “bone organ” with a size, structure, and functionality comparable to native bones. The work thus provides a model useful for fundamental and translational studies of bone morphogenesis and regeneration, as well as for the controlled manipulation of hematopoietic stem cell niches in physiology and pathology.